e-Therapeutics Raises $63M to Fund Solid Tumor Drug
e-Therapeutics plc is copper-bottoming its future, raising £40 million (US$62.66) in a share issue which, added to existing resources of £8 million, will fund the network pharmacology specialist until 2017.